Biohaven Ltd. — Form 10-Q
Filed August 10, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 18/100
What the filing says
Warren K. Volles' General Counsel and Chief Legal Officer employment agreement effective April 1, 2019, specifies base salary of $375,000 plus cost-of-living increases, bonus target of 35% of base, and seven equity option grants totaling 165,500 shares (April 2017–March 2019). Agreement includes standard severance (12 months base + COBRA + accelerated vesting for all options if terminated without cause), enhanced severance upon change-in-control, and 12-month post-termination non-compete with permitted activities in IPraxus Legal LLC and Kleo Pharmaceuticals consulting. Document signed by CEO Vlad Coric.
Why this rating
Routine executive employment disclosure. $375K salary + benefits immaterial (0.04% of $1B market cap). Equity grants (~165.5K shares, strike price unstated) ordinary for GC role. No change to current terms—agreement predates filing by 7+ years.
See more from August 10, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.